Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Urges Stockholders To Turn Down Roche's Offer & Vote For Its Nominees

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) said it is sending a letter from its Board of Directors highlighting supportive reports issued by two of the nation's leading proxy advisor firms. The company's Board recommends that stockholders reject Roche's (RHHBY.PK) offer and vote for the election of its highly qualified nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card on April 9, 2012.

Illumina also urged its shareholders to vote the WHITE PROXY CARD to re-elect to the Board four highly qualified and experienced directors, Blaine Bowman; Karin Eastham; Jay Flatley, President and CEO; and William Rastetter, Chairman.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.